SCHEMBL25869369

SCHEMBL25869369

CCc1ccnc(Cl)c1C(=O)OC(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATR Q13535 1/20 0.46
TDP1 Q9NUW8 1/20 0.40
POLB P06746 1/20 0.39
IGF1R P08069 1/20 0.34
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
GLA P06280 2/20 0.33
GAA P10253 2/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
HIF1A Q16665 2/20 0.33
LMNA P02545 1/20 0.33
THRB P10828 1/20 0.33
MEN1 O00255 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CASP3 P42574 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29350439 0.90 ATR (0.45) ATRTDP1POLBKMT2AKDM4E
SCHEMBL19778006 0.90 ATR (0.45) ATRTDP1POLBKMT2AKDM4E
SCHEMBL29350436 0.84 ATR (0.41) ATRTDP1POLBKMT2AKDM4E
SCHEMBL19778001 0.84 ATR (0.41) ATRTDP1POLBKMT2AKDM4E
SCHEMBL8530313 0.83 ATR (0.49) ATRTDP1POLBKMT2AKDM4E
SCHEMBL23970620 0.83 ATR (0.40) ATRTDP1POLBKMT2AKDM4E
SCHEMBL30496272 0.81 ATR (0.48) ATRTDP1POLBKMT2AALDH1A1
SCHEMBL8527621 0.81 ATR (0.48) ATRTDP1POLBKMT2AKDM4E
SCHEMBL25239851 0.81 ATR (0.48) ATRTDP1POLBKMT2AALDH1A1
SCHEMBL23971145 0.80 ATR (0.50) ATRTDP1POLBKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230322804-A1 REAGENTS FOR REVERSIBLY PROTECTING BIOLOGICAL MOLECULES bioMérieux (FR) 2023-10-12 US disclosed
US-11708375-B2 Reagents for reversibly protecting biological molecules bioMérieux (FR) 2023-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322804-A1 REAGENTS FOR REVERSIBLY PROTECTING BIOLOGICAL MOLECULES AZI2, TPMT, CA12 ATR 4689/4885TDP1 1559/4885POLB 943/4885
US-11708375-B2 Reagents for reversibly protecting biological molecules AZI2, TPMT, CA12 ATR 4689/4885TDP1 1559/4885POLB 943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.